logo

For the Inventor, By the Inventor

Redhill, United Kingdom

Barrie C Cantello

This inventor holds 25 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignee: Beecham Group Plc. Active years: 1976-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barrie C Cantello. Retrieved from https://idiyas.com/inventor/barrie-c-cantello

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 8

Forward Citations = 214(Granted Patents)


Location History:

  • Horsham, EN (1976 - 1977)
  • Redhill, GB (1981 - 1986)
  • Coulsdon, GB (1986 - 1988)
  • Epsom, GB (1990 - 1995)

Company Filing History:

goldMedal25 out of 855 
 
Beecham Group Plc
 patents

Years Active: 1976-1995

Loading Chart...
Areas of Expertise:
Dioxothiazolidine Compounds
Thiazolidinediones
Morpholine Derivatives
Secondary Amines
Hypoglycemic Activity
Benzimidazoline Derivatives
Heterocyclic Compounds
Coumarin Derivatives
Anti-Allergic Compositions
Prophylaxis
Asthma Treatments
Pharmaceutical Uses
25 patents (USPTO):Explore Patents
1. 5478851 - Dioxothiazolidine compounds (1995-12-26),
2. 5132317 - Compounds (1992-07-21),
3. 4918091 - Novel thiazolidinediones (1990-04-17),
4. 4783460 - Morpholine derivatives, compositions and medicinal uses (1988-11-08),
5. 4665072 - Morpholine derivatives, compositions and method of use (1987-05-12),
6. 4629737 - Secondary amines and use in pharmaceutical compositions (1986-12-16),
7. 4622342 - Secondary amines (1986-11-11),
8. 4607033 - Morpholine derivatives, compositions and medicinal use (1986-08-19),
9. 4409216 - Method of treating diabetes using oxazoline or thiazoline compounds (1983-10-11),
10. 4355004 - Benzimidazoline derivatives and pharmaceutical compositions containing (1982-10-19),
11. 4333929 - Carboxamidine derivatives and hypoglycemical use (1982-06-08),
12. 4282356 - Intermediates for heterocyclic imines having hypolipidaemic activity (1981-08-04),
13. 4250173 - Heterocyclic compounds and pharmaceutical use (1981-02-10),
14. 4065457 - 4-Hydroxy-3-nitro-carbostyril compounds (1977-12-27),
15. 4059704 - Tetrazole coumarin derivatives (1977-11-22),

Title: Barrie C Cantello: A Pioneer in Dioxothiazolidine Compounds

Introduction: Barrie C Cantello, located in Redhill, United Kingdom, is an accomplished inventor with a remarkable portfolio of 25 patents. His contributions to the field of chemistry, particularly in the development of dioxothiazolidine compounds, highlight his innovative spirit and dedication to advancing pharmaceutical science.

Latest Patents: Among Cantello's latest innovations is a patent for dioxothiazolidine compounds, which describes a compound of formula (I) or a tautomeric form thereof, along with its pharmaceutically acceptable salts and solvates. This invention opens new avenues for therapeutic applications, showcasing Cantello's expertise in developing complex chemical compounds.

Career Highlights: Throughout his career, Barrie has established himself as a vital contributor to the Beecham Group Plc. His work focuses on creating novel compounds that have the potential to address various medical challenges, thereby making a significant impact in the pharmaceutical industry.

Collaborations: Cantello collaborates closely with esteemed colleagues, including Derek R Buckle and Harry Smith. This teamwork fosters a culture of innovation and allows for the sharing of diverse expertise, enhancing the overall quality of their research and inventions.

Conclusion: Barrie C Cantello's journey as an inventor is marked by his impressive array of patents and continuous contributions to the field of pharmaceutical chemistry. His latest work on dioxothiazolidine compounds exemplifies his commitment to innovation and highlights the importance of collaboration in driving forward the frontiers of science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…